Daniel C. Martin, Chief Commercial Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 2,267 shares at $15.62 ($35K) on 2024-02-16, disclosed to the SEC on 2024-02-20.
Open-market sale of $35k DCPH by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DCPH | SELL | 2023-12-01 | $448K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $17K | — | Filing → |
| DCPH | SELL | 2023-06-21 | $18K | — | Filing → |